Publicaciones en las que colabora con Unax Lertxundi Etxebarria (24)

2024

  1. Medication impact on oral health in schizophrenia

    Medicina Oral Patologia Oral y Cirugia Bucal, Vol. 29, Núm. 1, pp. e51-e57

2023

  1. Analysis of heat stroke and heat exhaustion cases in EudraVigilance pharmacovigilance database

    European Journal of Clinical Pharmacology, Vol. 79, Núm. 5, pp. 679-685

2022

  1. Farmako antipsikotikoak eta aho-patologia: eragin kaltegarriak jakinarazteko Europako sistemaren bidezko analisia

    Osagaiz: osasun-zientzien aldizkaria, Vol. 6, Núm. 1, pp. 55-66

  2. Subacute thyroiditis and COVID-19 vaccines: a case/non-case study

    Endocrine, Vol. 77, Núm. 3, pp. 480-485

2021

  1. Antipsychotics as environmental pollutants: An underrated threat?

    Science of the Total Environment, Vol. 769

  2. Do cariprazine and brexpiprazole cause impulse control symptoms? A case/non-case study

    European Neuropsychopharmacology, Vol. 50, pp. 107-111

  3. Prophylactic laxatives in clozapine-treated patients: A long road ahead

    Revista de Psiquiatria Clinica, Vol. 48, Núm. 1, pp. 66-68

  4. SGLT2 Inhibitors and Bladder Cancer: Analysis of Cases Reported in the European Pharmacovigilance Database

    Journal of Clinical Pharmacology, Vol. 61, Núm. 2, pp. 187-192

  5. Tramadol-induced hiccups: a case–noncase study in the European pharmacovigilance database

    Therapeutic Advances in Drug Safety, Vol. 12

2019

  1. Antipsychotics and pituitary tumors: An analysis of the European pharmacovigilance database (EudraVigilance)

    International Clinical Psychopharmacology, Vol. 34, Núm. 2, pp. 89-92

  2. Fractures Related to Tenofovir: A Case/Noncase Study in the European Pharmacovigilance Database

    American journal of therapeutics, Vol. 26, Núm. 5, pp. e589-e592

2018

  1. Aripiprazole and impulse control disorders: Higher risk with the intramuscular depot formulation?

    International Clinical Psychopharmacology, Vol. 33, Núm. 1, pp. 56-58

2017

  1. Clozapine-Induced Cardiomyopathy in Parkinson's Disease

    Movement Disorders Clinical Practice

  2. Hiccups in Parkinson’s disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature

    European Journal of Clinical Pharmacology, Vol. 73, Núm. 9, pp. 1159-1164

2016

  1. Dipeptidyl peptidase-IV inhibitors induced bullous pemphigoid: A case report and analysis of cases reported in the European pharmacovigilance database

    Journal of Clinical Pharmacy and Therapeutics, Vol. 41, Núm. 3, pp. 368-370

2015

  1. Adverse reactions to antipsychotics in parkinson disease: An analysis of the Spanish Pharmacovigilance database

    Clinical Neuropharmacology, Vol. 38, Núm. 3, pp. 69-84

  2. Possible interaction between letrozole and long-acting injectable zuclopenthixol

    Nordic Journal of Psychiatry, Vol. 69, Núm. 1, pp. 79-80

2014

  1. Acute adverse reactions to iopromide vs iomeprol: A retrospective analysis of spontaneous reporting from a radiology department

    British Journal of Radiology, Vol. 87, Núm. 1033

2013

  1. Antipsychotics and seizures: Higher risk with atypicals?

    Seizure, Vol. 22, Núm. 2, pp. 141-143

  2. Domperidone in Parkinson's disease: a perilous arrhythmogenic or the gold standard?

    Current drug safety, Vol. 8, Núm. 1, pp. 63-68